These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 271071)

  • 21. [Evaluation of adjuvant chemotherapy of osteosarcoma with special reference to adriamycin (final report)].
    Maeyama I; Furuse K; Yamawaki S; Abe M; Tateishi A; Takeyama S; Furuya K; Fukuma H; Takeuchi S; Shinohara N
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3245-51. PubMed ID: 3196042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chronic toxicities of adriamycin (ADR) and their possible prevention by coenzyme Q10 and verapamil in rabbits--especially ADR induced cardiomyopathy (author's transl)].
    Dohmae N; Sawada H; Tashima M; Uchino H; Matsuyama E; Konishi T
    Nihon Gan Chiryo Gakkai Shi; 1979 Oct; 14(6):1009-28. PubMed ID: 541529
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose-response relationship of dexrazoxane for prevention of doxorubicin-induced cardiotoxicity in mice, rats, and dogs.
    Imondi AR; Della Torre P; Mazué G; Sullivan TM; Robbins TL; Hagerman LM; Podestà A; Pinciroli G
    Cancer Res; 1996 Sep; 56(18):4200-4. PubMed ID: 8797592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of dexrazoxane and other strategies to prevent cardiomyopathy associated with doxorubicin-taxane combinations.
    Sparano JA
    Semin Oncol; 1998 Aug; 25(4 Suppl 10):66-71. PubMed ID: 9768827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid.
    Cohen IJ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):579-81. PubMed ID: 14578026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevention of cardiotoxicity of doxorubicin (Adriamycin) using cardioxane (ICRF-187, dexrazoxane) in the combination chemotherapy of disseminated breast cancer].
    Gershanovich ML; Moiceenko VM; Orlova RV
    Vopr Onkol; 1993; 39(1-3):26-32. PubMed ID: 8073671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoresponsiveness of Moloney sarcoma virus-induced osteosarcoma to adriamycin in the rat.
    Olson HM; Capen CC
    Cancer Res; 1978 Jun; 38(6):1561-7. PubMed ID: 274173
    [No Abstract]   [Full Text] [Related]  

  • 28. [Doxorubicin-induced cardiomyopathy: hemodynamic studies for evaluating the limit of therapeutic risk].
    Lenzhofer R; Magometschnigg D
    Z Kardiol; 1983 May; 72(5):297-303. PubMed ID: 6880337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Chemotherapy of osteosarcoma (author's transl)].
    Winkler K; Gaedicke G; Grosch-Wörner I; Marsmann G; Delling G; Landbeck G
    Dtsch Med Wochenschr; 1977 Dec; 102(50):1831-5. PubMed ID: 303980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of thyroid hormone supplementation on chronic doxorubicin (adriamycin)-induced cardiotoxicity and serum concentrations of T3 and T4 in dogs.
    Van Vleet JF; Ferrans VJ; Badylak SF
    Am J Vet Res; 1982 Dec; 43(12):2173-82. PubMed ID: 6891885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-course study on doxorubicin-induced nephropathy and cardiomyopathy in male and female LOU/M/Wsl rats: lack of evidence for a causal relationship.
    van Hoesel QG; Steerenberg PA; Dormans JA; de Jong WH; de Wildt DJ; Vos JG
    J Natl Cancer Inst; 1986 Feb; 76(2):299-307. PubMed ID: 3456068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults.
    Hequet O; Le QH; Moullet I; Pauli E; Salles G; Espinouse D; Dumontet C; Thieblemont C; Arnaud P; Antal D; Bouafia F; Coiffier B
    J Clin Oncol; 2004 May; 22(10):1864-71. PubMed ID: 15143078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripartum heart failure in a patient treated previously with doxorubicin.
    Davis LE; Brown CE
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):506-8. PubMed ID: 3162299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use and side effects of chemotherapy in the treatment of malignant bone tumors (osteosarcoma and Ewing's sarcoma) (author's transl)].
    Prindull G; Poppe H; Fuchs K
    Unfallheilkunde; 1979 Dec; 82(12):517-21. PubMed ID: 296860
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
    Kotz R; Leber H; Ramach W; Arbes H; Wolf A
    Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed and progressive myocardial lesions after adriamycin administration in the rabbit.
    Jaenke RS
    Cancer Res; 1976 Aug; 36(8):2958-66. PubMed ID: 1277204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
    Prindull G; Poppe H; Jentsch E; Schauer A
    Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
    Mohamed HE; Asker ME; Ali SI; el-Fattah TM
    J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?].
    Reinhardt D; Hofmann V; Martz G
    Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.